Increased Th17 cells and interleukin-17 contribute to immune activation and disease aggravation in patients with chronic hepatitis B virus infection

Immunology Letters

Volumn 149, Issue 1-2, 2013, Pages 41-49

  Yang, Bo ^a   Wang, Yadong ^a   Zhao, Caiyan ^a   Yan, Wenzhao ^a   Che, Honghao ^a   Shen, Chuan ^a   Zhao, Meng ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Acute on chronic; Chronic; Hepatitis B; Interleukin 17; Liver failure; Th17 cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; HEPATITIS B; HUMAN; HUMAN TISSUE; IMMUNOMODULATION; INTERNATIONAL NORMALIZED RATIO; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TH17 CELL; UPREGULATION;

ADULT; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERLEUKIN-17; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; RNA, MESSENGER; SURVIVAL RATE; TH17 CELLS;

EID: 84872734446     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2012.12.001     Document Type: Article

References (40)

1. World Health Organization. Hepatitis B (fact sheet no. 204); July 2012. [23.09.12]. http://www.who.int/mediacentre/factsheets/fs204/en/.
2. Chisari F.V., Isogawa M., Wieland S.F. Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris) 2010, 58:258-266.
3. Jin B., Sun T., Yu X.H., Yang Y.X., Yeo A.E. The effects of TLR activation on T-cell development and differentiation. Clin Dev Immunol 2012, 2012:836485.
4. Waite J.C., Skokos D. Th17 response and inflammatory autoimmune diseases. Int J Inflam 2012, 2012:819467.
5. Hu Y., Shen F., Crellin N.K., Ouyang W. The IL-17 pathway as a major therapeutic target in autoimmune diseases. Ann N Y Acad Sci 2011, 1217:60-76.
6. Wilke C.M., Kryczek I., Wei S., Zhao E., Wu K., Wang G., et al. Th17 cells in cancer: help or hindrance. Carcinogenesis 2011, 32:643-649.
7. Ji Y., Zhang W. Th17 cells: positive or negative role in tumor. Cancer Immunol Immunother 2010, 59:979-987.
8. Chadha R., Heidt S., Jones N.D., Wood K.J. Th17: contributors to allograft rejection and a barrier to the induction of transplantation tolerance. Transplantation 2011, 91:939-945.
9. Heidt S., Segundo D.S., Chadha R., Wood K.J. The impact of Th17 cells on transplant rejection and the induction of tolerance. Curr Opin Organ Transplant 2010, 15:456-461.
10. Zhang J.Y., Zhang Z., Lin F., Zou Z.S., Xu R.N., Jin L., et al. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 2010, 51:81-91.
11. Wu W., Li J., Chen F., Zhu H., Peng G., Chen Z. Peripheral Th17 cells frequency is associated with the disease progression in HBV infected patients. J Gastroenterol Hepatol 2010, 25:750-757.
12. Ge J., Wang K., Meng Q.H., Qi Z.X., Meng F.L., Fan Y.C. Implication of Th17 and Th1 cells in patients with chronic active hepatitis B. J Clin Immunol 2010, 30:60-67.
13. Apostolidis S.A., Crispín J.C., Tsokos G.C. IL-17-producing T cells in lupus nephritis. Lupus 2011, 20:120-124.
14. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005, 6:1133-1141.
15. Lafdil F., Miller A.M., Ki S.H., Gao B. Th17 cells and their associated cytokines in liver diseases. Cell Mol Immunol 2010, 7:250-254.
16. Lemmers A., Moreno C., Gustot T., Maréchal R., Degré D., Demetter P., et al. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 2009, 49:646-657.
17. Harada K., Shimoda S., Sato Y., Isse K., Ikeda H., Nakanuma Y. Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis. Clin Exp Immunol 2009, 157:261-270.
18. Wang L., Chen S., Xu K. IL-17 expression is correlated with hepatitis B-related liver diseases and fibrosis. Int J Mol Med 2011, 27:385-392.
19. Ye Y., Xie X., Yu J., Zhou L., Xie H., Jiang G., et al. Involvement of Th17 and Th1 effector responses in patients with hepatitis B. J Clin Immunol 2010, 30:546-555.
20. Yasumi Y., Takikawa Y., Endo R., Suzuki K. Interleukin-17 as a new marker of severity of acute hepatic injury. Hepatol Res 2007, 37:248-254.
21. Xu S., Han Y., Xu X., Bao Y., Zhang M., Cao X. IL-17A-producing gammadeltaT cells promote CTL responses against Listeria monocytogenes infection by enhancing dendritic cell cross-presentation. J Immunol 2010, 185(10):5879-5887.
22. Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association The guideline of prevention and treatment for chronic hepatitis B (2010 version). Zhonghua Gan Zang Bing Za Zhi 2011, 19:13-24. [Article in Chinese].
23. Sarin S.K., Kumar A., Almeida J.A., Chawla Y.K., Fan S.T., Garg H., et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 2009, 3:269-282.
24. Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association Diagnostic and treatment guidelines for liver failure. Zhonghua Gan Zang Bing Za Zhi 2006, 14:643-646. [Article in Chinese].
25. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24:179-189.
26. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
27. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006, 441:231-234.
28. Afzali B., Lombardi G., Lechler R.I., Lord G.M. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007, 148:32-46.
29. Kolls J.K., Lindén A. Interleukin-17 family members and inflammation. Immunity 2004, 21:467-476.
30. Hou W., Kang H.S., Kim B.S. Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection. J Exp Med 2009, 206:313-328.
31. Wang L.Y., Meng Q.H., Zou Z.Q., Fan Y.C., Han J., Qi Z.X., et al. Increased frequency of peripheral Th17 cells in acute-on-chronic hepatitis B liver failure. Dig Dis Sci 2012, 57:667-674.
32. Xue-Song L., Cheng-Zhong L., Ying Z., Mo-Bin W. Changes of Treg and Th17 cells balance in the development of acute and chronic hepatitis B virus infection. BMC Gastroenterol 2012, 12:43.
33. Kim W.R., Flamm S.L., Di Bisceglie A.M., Bodenheimer H.C. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology 2008, 47:1363-1370.
34. Sun Q.F., Ding J.G., Xu D.Z., Chen Y.P., Hong L., Ye Z.Y., et al. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model. J Viral Hepat 2009, 16:464-470.
35. Said A., Williams J., Holden J., Remington P., Gangnon R., Musat A., et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004, 40:897-903.
36. Niu Y., Liu H., Yin D., Yi R., Chen T., Xue H., et al. The balance between intrahepatic IL-17(+) T cells and Foxp3(+) regulatory T cells plays an important role in HBV related end-stage liver disease. BMC Immunol 2011, 12:47.
37. Dardalhon V., Korn T., Kuchroo V.K., Anderson A.C. Role of Th1 and Th17 cells in organ-specific autoimmunity. J Autoimmun 2008, 31(3):252-256.
38. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201(2):233-240.
39. Stauber R.E., Wagner D., Stadlbauer V., Palma S., Gurakuqi G., Kniepeiss D., et al. Evaluation of indocyanine green clearance and model for end-stage liver disease for estimation of short-term prognosis in decompensated cirrhosis. Liver Int 2009, 29:1516-1520.
40. Xu M., Morishima N., Mizoguchi I., Chiba Y., Fujita K., Kuroda M., et al. Regulation of the development of acute hepatitis by IL-23 through IL-22 and IL-17 production. Eur J Immunol 2011, 41(10):2828-2839.